Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma

Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma

BackgroundCancer stem cells (CSCs) have been proven to influence drug resistance, recurrence, and metastasis in tumors. Our study aimed to identify stemness-related prognostic biomarkers for new therapeutic strategies in adrenocortical carcinoma.MethodsRNA-seq data and clinical characteristics were...

Full description

Bibliographic Details
Main Authors:	Xiaoxi Shi, Yuanlin Liu, Shuai Cheng, Haidi Hu, Jian Zhang, Minjie Wei, Lin Zhao, Shijie Xin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Oncology
Subjects:	adrenocortical carcinoma cancer stemness immune cell infiltration immune checkpoint inhibitors WGCNA
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.651622/full

Similar Items

The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma
by: Izabela Karwacka, et al.
Published: (2021-01-01)

Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success?
by: Natalia Georgantzoglou, et al.
Published: (2021-04-01)

Medical Approaches in Adrenocortical Carcinoma
by: Rosa Maria Paragliola, et al.
Published: (2020-11-01)

Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data
by: Xi Tian, et al.
Published: (2020-01-01)

The Immunotherapy Landscape in Adrenocortical Cancer
by: Guillaume J. Pegna, et al.
Published: (2021-05-01)

High copy number variations, particular transcription factors, and low immunity contribute to the stemness of prostate cancer cells
by: Zao Dai, et al.
Published: (2021-05-01)

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
by: Emilien Billon, et al.
Published: (2019-11-01)

The Prognostic Role of CD8<sup>+</sup> T Lymphocytes in Childhood Adrenocortical Carcinomas Compared to Ki-67, PD-1, PD-L1, and the Weiss Score
by: Ivy Zortéa S. Parise, et al.
Published: (2019-11-01)

Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance
by: Marta Araujo-Castro, et al.
Published: (2021-03-01)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
by: Yunfei Chen, et al.
Published: (2021-07-01)

Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma
by: Shaojian Lin, et al.
Published: (2020-10-01)

Apoptosis regulation in adrenocortical carcinoma
by: Sofia S Pereira, et al.
Published: (2019-05-01)

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
by: Elisabet Cuyàs, et al.
Published: (2020-07-01)

Co-expression Network Analysis of Biomarkers for Adrenocortical Carcinoma
by: Lushun Yuan, et al.
Published: (2018-08-01)

The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma
by: Liliana Montella, et al.
Published: (2021-07-01)

GNRH1 and LTB4R might be novel immune-related prognostic biomarkers in clear cell renal cell carcinoma (ccRCC)
by: Hua-Hui Wu, et al.
Published: (2021-07-01)

Adrenocortical tumors in children
by: R.C. Ribeiro, et al.
Published: (2000-10-01)

Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC
by: Mabrouka Doghman-Bouguerra, et al.
Published: (2020-03-01)

Large functioning Childhood adrenocortical carcinoma (Case report)
by: Jinan A. Jabbar, et al.
Published: (2014-01-01)

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy
by: Zhenfei Xiang, et al.
Published: (2021-01-01)

Novel immunotherapy in metastatic renal cell carcinoma
by: Yang Hyun Cho, et al.
Published: (2017-07-01)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
by: Yuqing He, et al.
Published: (2021-09-01)

An Interesting Case of Hepatic Adrenocortical Carcinoma
by: Hikmat Permana, et al.
Published: (2018-10-01)

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01)

Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA
by: Rongjia Su, et al.
Published: (2021-08-01)

Screening of biomarkers for the diagnosis and prognosis of adrenocortical carcinoma based on bioinformatics analysis
by: De-Lian Zhang, et al.
Published: (2021-05-01)

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion
by: Liu S, et al.
Published: (2018-04-01)

Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives
by: Daniel M. Girardi, et al.
Published: (2021-12-01)

Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic Efficacy: A Computational Retrospective Study
by: Rong Liu, et al.
Published: (2021-06-01)

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
by: Mouhammed Amir Habra, et al.
Published: (2019-09-01)

Immunotherapy in urothelial cancer: recent data and perspectives
by: M. I. Volkova, et al.
Published: (2018-01-01)

High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma
by: Wu J, et al.
Published: (2020-10-01)

The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
by: Feng Li, et al.
Published: (2021-11-01)

Adrenocortical carcinoma (ACC): diagnosis, prognosis and treatment.
by: Rossella eLibé
Published: (2015-07-01)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
by: Ariel E. Marciscano, et al.
Published: (2018-01-01)

Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
by: Ziniu Ding, et al.
Published: (2021-09-01)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
by: Rui Cao, et al.
Published: (2020-06-01)

Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma
by: Hye-Won Lee
Published: (2021-06-01)

Adrenocortical carcinoma’s incidence and mortality in central Serbia
by: Jovanović Milan D., et al.
Published: (2017-01-01)

Tumor-Infiltrating Lymphocytes and Breast Cancer: Are Immune Checkpoint Inhibitors Ready for Prime Time in Breast Cancer?
by: Cvetanović Ana, et al.
Published: (2016-12-01)